Get the Stockscreener App
56.01
0.44%
-0.25
After Hours:
56.01
State Street Spdr S P Pharmaceuticals Etf stock is traded at $56.01, with a volume of 50,571.
It is down -0.44% in the last 24 hours and up +2.21% over the past month.
See More
Previous Close:
$56.26
Open:
$56.05
24h Volume:
50,571
Relative Volume:
0.84
Market Cap:
$229.97M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.69%
1M Performance:
+2.21%
6M Performance:
+38.02%
1Y Performance:
+30.29%
1-Day Range:
$55.85
$56.39
1-Week Range:
$55.85
$57.52
52-Week Range:
$35.22
$57.58
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Company Profile
Name
State Street Spdr S P Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare XPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XPH
State Street Spdr S P Pharmaceuticals Etf
|
56.01 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.27 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
681.92 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
684.94 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
257.95 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
614.31 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Latest News
The Year-End 2025 Biotech Rally And What It Means For 2026 - Benzinga
Is State Street SPDR S&P Homebuilders ETF (XHB) a Strong ETF Right Now? - Yahoo Finance
Chart of the Week: Moderna Stock May Be Finding a Bottom - Barron's
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - MSN
Is State Street SPDR S&P Software & Services ETF (XSW) a Strong ETF Right Now? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Homebuilders ETF (XHB)? - Nasdaq
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Sahm
Bet on These Top-Ranked Healthcare ETFs Before 2025 Ends - The Globe and Mail
Should You Invest in the State Street SPDR S&P Oil & Gas Equipment & Services ETF (XES)? - Yahoo Finance
Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts - Benzinga
Should State Street SPDR Portfolio S&P 600 Small Cap ETF (SPSM) Be on Your Investing Radar? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Aerospace & Defense ETF (XAR)? - Yahoo Finance
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)? - MSN
6 Top-Performing ETF Areas of Last Week - TradingView — Track All Markets
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
Is State Street SPDR Portfolio S&P 500 High Dividend ETF (SPYD) a Strong ETF Right Now? - Yahoo Finance
Pharma ETF (XPH) hits a new 52-week high - MSN
Short bets on S&P 500 Healthcare sector rises to 2.12% in November; MRNA stays most shorted stock - Seeking Alpha
Should State Street SPDR S&P Dividend ETF (SDY) Be on Your Investing Radar? - Yahoo Finance
Eight stock picks to play one of the healthiest corners of the market - MarketWatch
Should You Invest in the State Street SPDR S&P Regional Banking ETF (KRE)? - Yahoo Finance
3 Undervalued ETFs to Buy Before 2026 - TradingView — Track All Markets
Should State Street SPDR S&P 600 Small Cap Growth ETF (SLYG) Be on Your Investing Radar? - Yahoo Finance
Should you invest in the First Trust Health Care AlphaDEX ETF (FXH)? - MSN
Pfizer partners with YaoPharma to develop weight management drug - MSN
Pharma ETF (XPH) Hits a New 52-Week High - Yahoo Finance
Should You Invest in the State Street SPDR S&P Software & Services ETF (XSW)? - Yahoo Finance
Is State Street SPDR S&P Dividend ETF (SDY) a Strong ETF Right Now? - Yahoo Finance
The Biotech Industry Is Healthier Than Investors Think. The Stocks to Watch. - Barron's
The Biotech Industry Is Healthier Than Investors Think. These Are the Stocks to Watch. - Barron's
Meet the New AI Winners: Alphabet, Tesla and Even Big Pharma and Biotech - Barron's
State Street SPDR S&P 1500 Momentum Tilt ETF Holdings - Quiver Quantitative
Two Sector ETFs Are Quietly Outperforming the S&P 500 Without a Single AI Stock - AOL.com
Best-Performing ETFs of November - TradingView
Should State Street SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing Radar? - Yahoo Finance
Is State Street SPDR S&P Capital Markets ETF (KCE) a Strong ETF Right Now? - Yahoo Finance
State Street SPDR and iShares ETFs Deliver Strong Growth Without AI Stocks - cointurk finance
SPYM: S&P 500 Monthly Dashboard For December - Seeking Alpha
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - MSN
Should State Street SPDR Portfolio S&P 400 Mid Cap ETF (SPMD) Be on Your Investing Radar? - sharewise.com
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
IHE: Pharma Powerhouse ETF Despite High Fees And Valuation (NYSEARCA:IHE) - Seeking Alpha
Here's How Many Shares of the SPDR S&P Dividend ETF (SDY) You'd Need for $500 in Yearly Dividends - AOL.com
Should State Street SPDR Portfolio S&P 500 ETF (SPYM) Be on Your Investing Radar? - Yahoo Finance
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Financials Data
There is no financial data for State Street Spdr S P Pharmaceuticals Etf (XPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):